Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹670Cr
Rev Gr TTM
Revenue Growth TTM
0.86%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

TRANSPEK
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 42.1 | -23.3 | -44.0 | -24.5 | -26.9 | -6.3 | 34.5 | 14.6 | 11.5 | 1.6 | -1.5 | -6.8 |
| 163 | 140 | 108 | 121 | 129 | 136 | 140 | 146 | 133 | 130 | 134 | 134 |
Operating Profit Operating ProfitCr |
| 19.8 | 13.9 | 11.1 | 18.7 | 12.7 | 10.5 | 13.8 | 14.1 | 19.5 | 15.6 | 16.6 | 15.7 |
Other Income Other IncomeCr | 5 | 12 | 4 | 5 | 5 | 11 | 5 | 5 | 8 | 12 | 5 | 4 |
Interest Expense Interest ExpenseCr | 6 | 4 | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 |
Depreciation DepreciationCr | 8 | 9 | 9 | 9 | 11 | 12 | 13 | 12 | 13 | 12 | 12 | 12 |
| 31 | 21 | 6 | 20 | 9 | 12 | 12 | 14 | 25 | 21 | 17 | 14 |
| 9 | 5 | 3 | 6 | 3 | 2 | 2 | 3 | 5 | 5 | 4 | 4 |
|
Growth YoY PAT Growth YoY% | 97.8 | -3.4 | -85.0 | -43.0 | -74.8 | -41.4 | 219.4 | -24.4 | 241.3 | 67.7 | 32.4 | 1.9 |
| 11.0 | 9.8 | 2.5 | 9.5 | 3.8 | 6.1 | 5.9 | 6.3 | 11.7 | 10.1 | 7.9 | 6.8 |
| 40.1 | 28.4 | 5.4 | 25.2 | 10.1 | 16.6 | 17.1 | 19.1 | 34.5 | 27.9 | 22.6 | 19.4 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| 7.6 | -2.0 | 11.6 | 14.1 | 64.6 | -4.9 | -40.0 | 76.5 | 38.0 | -29.9 | 12.1 | -1.8 |
| 251 | 237 | 264 | 314 | 478 | 448 | 292 | 503 | 680 | 497 | 555 | 530 |
Operating Profit Operating ProfitCr |
| 13.2 | 16.5 | 16.6 | 13.0 | 19.6 | 20.8 | 13.9 | 16.0 | 17.8 | 14.2 | 14.6 | 16.9 |
Other Income Other IncomeCr | 11 | 4 | 7 | 10 | 18 | 17 | 17 | 28 | 18 | 25 | 29 | 28 |
Interest Expense Interest ExpenseCr | 13 | 11 | 9 | 12 | 19 | 16 | 10 | 11 | 19 | 14 | 12 | 9 |
Depreciation DepreciationCr | 9 | 8 | 9 | 10 | 14 | 26 | 29 | 30 | 33 | 38 | 50 | 50 |
| 27 | 32 | 42 | 35 | 101 | 94 | 26 | 84 | 113 | 56 | 62 | 77 |
| 5 | 10 | 12 | 9 | 36 | 21 | 2 | 19 | 29 | 17 | 13 | 19 |
|
| 191.6 | -3.1 | 40.9 | -11.9 | 149.0 | 11.0 | -68.0 | 180.6 | 27.6 | -53.8 | 26.4 | 19.7 |
| 7.6 | 7.5 | 9.5 | 7.3 | 11.1 | 12.9 | 6.9 | 10.9 | 10.1 | 6.7 | 7.5 | 9.1 |
| 37.4 | 36.2 | 51.9 | 47.3 | 117.7 | 130.6 | 41.7 | 117.1 | 149.4 | 69.0 | 87.3 | 104.4 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| 69 | 85 | 200 | 241 | 306 | 333 | 374 | 479 | 581 | 668 | 740 | 762 |
Current Liabilities Current LiabilitiesCr | 106 | 74 | 109 | 183 | 154 | 136 | 106 | 166 | 136 | 113 | 122 | 99 |
Non Current Liabilities Non Current LiabilitiesCr | 48 | 44 | 71 | 136 | 133 | 114 | 113 | 114 | 165 | 180 | 133 | 133 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 118 | 95 | 119 | 177 | 173 | 159 | 154 | 244 | 234 | 214 | 301 | 290 |
Non Current Assets Non Current AssetsCr | 111 | 114 | 267 | 389 | 426 | 430 | 446 | 520 | 652 | 752 | 699 | 709 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 19 | 44 | 47 | 7 | 128 | 111 | 35 | 47 | 111 | 98 | 135 |
Investing Cash Flow Investing Cash FlowCr | 14 | -16 | -31 | -103 | -45 | -33 | -17 | -70 | -13 | -32 | -30 |
Financing Cash Flow Financing Cash FlowCr | -33 | -27 | -17 | 96 | -83 | -77 | -3 | 9 | -94 | -64 | -56 |
|
Free Cash Flow Free Cash FlowCr | 24 | 27 | 47 | -112 | 80 | 74 | 20 | 9 | 66 | 60 | 116 |
| 86.0 | 206.2 | 156.8 | 27.9 | 194.0 | 151.6 | 148.1 | 72.0 | 132.8 | 253.6 | 277.1 |
CFO To EBITDA CFO To EBITDA% | 49.5 | 93.9 | 89.2 | 15.7 | 109.4 | 93.8 | 73.1 | 49.0 | 75.3 | 118.8 | 142.7 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 142 | 233 | 330 | 689 | 839 | 686 | 762 | 1,089 | 822 | 994 | 697 |
Price To Earnings Price To Earnings | 6.6 | 11.4 | 11.0 | 26.1 | 12.8 | 9.4 | 32.7 | 16.7 | 9.8 | 25.8 | 14.3 |
Price To Sales Price To Sales | 0.5 | 0.8 | 1.0 | 1.9 | 1.4 | 1.2 | 2.2 | 1.8 | 1.0 | 1.7 | 1.1 |
Price To Book Price To Book | 1.9 | 2.6 | 1.6 | 2.8 | 2.7 | 2.0 | 2.0 | 2.3 | 1.4 | 1.5 | 0.9 |
| 5.5 | 6.1 | 7.6 | 18.4 | 8.2 | 6.5 | 18.0 | 12.2 | 6.4 | 13.2 | 7.3 |
Profitability Ratios Profitability Ratios |
| 49.3 | 56.2 | 53.1 | 46.8 | 49.4 | 54.0 | 52.1 | 47.5 | 47.0 | 50.4 | 48.8 |
| 13.2 | 16.5 | 16.6 | 13.0 | 19.6 | 20.8 | 13.9 | 16.0 | 17.8 | 14.2 | 14.6 |
| 7.6 | 7.5 | 9.5 | 7.3 | 11.1 | 12.9 | 6.9 | 10.9 | 10.1 | 6.7 | 7.5 |
| 27.1 | 28.8 | 18.7 | 11.0 | 27.9 | 25.8 | 7.3 | 15.3 | 18.1 | 8.8 | 8.7 |
| 29.4 | 23.4 | 14.6 | 10.7 | 21.1 | 21.6 | 6.1 | 13.5 | 14.2 | 5.7 | 6.5 |
| 9.6 | 10.2 | 7.8 | 4.7 | 11.0 | 12.4 | 3.9 | 8.6 | 9.4 | 4.0 | 4.9 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Company Snapshot**
- **Name**: Transpek Industry Limited
- **Founded**: 1965 (transitioned into chemical manufacturing in 1968)
- **Headquarters**: Vadodara, Gujarat, India
- **Core Expertise**: Chlorinated and sulphur-based chemistry, specializing in **Acid Chlorides**, **Alkyl Chlorides**, and **Thionyl Chloride**
- **Established Recognition**: First company in Asia to produce Thionyl Chloride (1979); pioneer of Chloro Acetyl Chloride in India (1987)
---
### **Operations & Infrastructure**
- **Manufacturing Site**: Ekalbara, Gujarat – a 100-acre facility located within a major chemical industrial zone, ~25 km from Vadodara.
- **Total Production Capacity**: 66,000 metric tons per annum (MTPA), including captive consumption
- **Merchantable Sales Capacity**: ~30,000 MTPA (15,600 MTPA in-house, the rest via job work arrangements)
- **Site Features**:
- Multipurpose, multi-product plants equipped for advanced chlorination, sulfonation, Friedel-Crafts, and amidation reactions.
- Process automation for consistent quality, energy-efficient technologies, and 100% water recycling using harvested rainwater.
- In-house ISO tank station managing over 600 ISO tanks with continuous monitoring; compliant with IMDG and IATA standards.
- **Strategic Location**: Proximity to major seaports (Nhava Sheva, Mundra, Pipavav, Hazira) and rail connectivity via Vadodara Inland Container Depot (ICD).
---
### **R&D and Innovation**
- **DSIR-Recognized R&D Facility**: Dedicated center approved by the Department of Science & Technology, Government of India.
- **Technical Scale-Up Capabilities**: Full pipeline from gram-scale labs → kilo labs → pilot plants → commercial production.
- **Academic Collaboration**: Approved by **Maharaja Sayajirao University of Vadodara** for Ph.D. research, reinforcing technical credibility and innovation pipeline.
- **Development Pipeline (Feb 2023)**: 15–17 new molecules under various stages of R&D, kilo lab testing, or pilot production, with each having an estimated revenue potential of ₹20–30 crores.
- **Recent Innovations (2024–25)**:
- Commercialized high-value products: Iso Pivaloyl Chloride, Thionyl Chloride, Sulphur Dichloride, 2-Methoxyethyl Chloride, Diethylene Glycol Dichloride.
- Developed and validated **three non-acid chloride products** with global customers (2025).
- **R&D Focus Areas**: Expansion beyond chlorination chemistry into **nitration**, **organic peroxides**, **photoinitiators**, **battery chemicals**, and **electronics-grade intermediates**.
---
### **Product Portfolio & Applications**
- **Core Products**:
- Acid Chlorides (e.g., Pivaloyl, Iso Pivaloyl, Acetyl)
- Alkyl Chlorides (e.g., 2-Methoxyethyl Chloride, 2-Propoxyethyl Chloride)
- Thionyl Chloride, Sulphur Dichloride, Oxalyl Chloride
- Custom chlorinated and sulphur-based specialty chemicals
- **End-Use Industries**:
- **Polymers & Plastics** (largest revenue contributor – >58% in first nine months of FY25)
- Pharmaceuticals (domestic focus; export opportunities emerging)
- Agrochemicals (limited presence; strategic caution due to pricing pressure)
- Cosmetics, Dyes, Pigments, Personal Care, Organic Peroxides
- Defense, Aerospace, Battery Chemicals, Electronics (mission-critical applications)
---
### **Global Business & Market Presence**
- **Export-Driven Model**: Over **85% of revenue from exports**, up to 87% in FY24
- **International Markets**: Supplies to **15+ countries** across:
- North America (USA, Mexico)
- Europe (Germany, France, Italy, Belgium, Spain, Switzerland, Turkey)
- Asia (Japan, South Korea, China, India)
- South America (Brazil) and Eurasia
- **Global Customers**: Long-term relationships with major multinational chemical companies; recognized since 1986 as a pioneering Indian chemical exporter.
- **Strategic Geographic Expansion**: Recent entry into **Japan, South America, and Eurasia**, with active customer engagements and growing traction.
- **Customer-Centric Innovation**: Collaborative product development with clients in US, Europe, and Japan to co-create tailored solutions meeting regulatory and technical requirements.
---
### **Strategic Initiatives & Growth Plan**
- **Diversification Strategy**:
- Reducing reliance on acid chlorides and concentrated customer segments.
- Developing non-chlorination and value-added multi-synthesis products.
- Target: **30–35% of business from high-margin products** within 3–4 years.
- **Expansion Approach**:
- Organic: Greenfield/brownfield site evaluation due to space constraints at current facility (limited by environmental norms).
- Inorganic: Actively evaluating acquisitions in complementary chemistry chains; no deals concluded yet due to lack of suitable targets.
- Low-risk modifications: Upgrading existing facilities; leveraging job work network for additional capacity.
- **Regulatory & Investment Status**:
- Preliminary approval for additional 450 MTPM capacity increase (pending final clearance; limited to 250 MTPM under current norms).
- ₹35 crore invested in new plant commissioning (Jun 2024), replacing outdated infrastructure and enabling higher output.
- **Sustainability & ESG**:
- 100% water recycling, ~35,000 trees on-site, green belt covering ~55% of premises.
- Awarded for energy conservation (2018–2021).
- Committed to global HSE standards; ISO tank fleet ensures safe transport of hazardous materials (e.g., Cl₂, SO₂, HCl).